U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: February 10-16, 2019
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: February 10-16, 2019

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Scott Gottlieb, M.D., Commissioner of Food and Drugs

Event Date: 02/12/2019
Location: Washington, DC
Subject: Dr. Nathan Davis Awards for Outstanding Government Service
FDA Participant/Group: CARLYLE MCWILLIAMS;
Non FDA Participant/Group: Government, academia, industry, and other invited guests

Official Name: Patrizia Cavazzoni, M.D., (Acting), Deputy Director for Operation, CDER

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 02/13/2019
Location: Dallas, TX
Subject: Romaine Task Force Produce Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members from the Romaine Task Force

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Keagan Lenihan, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 02/11/2019
Location: Alexandria, VA
Subject: Navigating the Nexus between Regulatory Science Policy and Entrepreneurship Biofabrication/Biomanufacturing Workshop
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives from the academic researchers association, administrators, entrepreneurs, industry leaders, regulatory and policy representatives, investors, and funding agency officers

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 02/13/2019
Location: Silver Spring, MD
Subject: Diabetic Medical Devices and Neuromodulation Closed Loop Technology
FDA Participant/Group: TIMOTHY STENZEL; PAMELA SCOTT; DONALD ST PIERRE; TIMOTHY MARJENIN;
Non FDA Participant/Group: Alejandro Galindo, Ali Dianaty, David Breiter, Geoff Martha, Hooman Hakami, Luann Pendy, Mike Coyle, Nicole Stanchina, Patrick Johnson, Ricahrd Kuntz, Robert Raike, Robert Vigersky, Steven Goetz, Tim Samsel (Medtronic);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 02/11/2019
Location: Washington, DC
Subject: 8th Annual Food Policy Impact on the Overview and Update: Center for Food Safety and Applied Nutrition Initiatives
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives from the Institute of Food Technologists, American Society for Nutrition, and other guests from the food industry

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event